 |
Small Molecule Inhibitor of Exon 17 mutant KIT |
|---|---|
| Trade Name | |
| Orphan Indication | Gastrointestinal Stromal Tumors |
| USA Market Approval | USA |
| USA Designation Date | 2016-01-06 00:00:00 |
| Sponsor | Blueprint Medicines Corporation;38 Sidney Street, Suite 200;Cambridge, Massachusetts, 02139 |
